![Dana Schmidt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Dana Schmidt has worked as the Head of Research and Development at oncgnostics GmbH since 2012.
Postes actifs de Dana Schmidt
Sociétés | Poste | Début |
---|---|---|
oncgnostics GmbH
![]() oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Corporate Officer/Principal | 01/10/2012 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
oncgnostics GmbH
![]() oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Health Technology |